as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
2.16%
Downside
2.61%
Upside
52 Week's Low
52 Week's High
34.52%
Downside
81.17%
Upside
Check Vera Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.8B
EPS (TTM)
-4.5466
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-269.8M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-73.25%
Compare market cap, revenue, PE, and other key metrics of Vera Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.8B | NA | NA | 0.00% | |
| BUY | $60.0B | 247.38% | 1448.9 | 1.36% | |
| NA | $43.9B | NA | 717.29 | 1.38% | |
| BUY | $110.9B | 96.07% | 30.76 | 31.35% | |
| BUY | $73.0B | 28.87% | 16.61 | 32.13% |
The Vera Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Vera Therapeutics Inc investment value today
Current value as on today
₹66,418
Returns
Returns from Vera Therapeutics Inc Stock
Dollar Returns*
₹5,242 (+5.24%)
Based on 16 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Vera Therapeutics Inc. Average target price of $61.83
Get share price movements and forecasts by analysts on Vera Therapeutics Inc.
What analysts predicted
54.23%UPSIDE
Target Price
$61.83
Current Price
$28.3
Analyzed by
16 Analysts
Target
$61.83
Vera Therapeutics Inc target price $61.83, a slight upside of 54.23% compared to current price of $28.3. According to 16 analysts rating.
Search interest for Vera Therapeutics Inc Stock has increased by 82% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:82% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, VERA has outperformed top 5 stocks with highest market-cap in Textiles & Leather Goods
Price Rise
![]()
In the last 3 years, VERA stock has moved up by 121.9%
Price Rise
![]()
In the last 7 days, VERA stock has moved up by 2.2%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 82.4% return, outperforming this stock by 5.2%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 31.34% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 93.3% return, outperforming this stock by 132.0%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 68.66% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, K P R Mill Ltd has given 20.1% return, outperforming this stock by 44.9%
| Organisation | Vera Therapeutics Inc |
| Headquarters | 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
| Industry | Services |
| CEO | Dr. Marshall W. Fordyce M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Marshall W. Fordyce M.D. | Founder, President, CEO & Director |
Dr. Robert M. Brenner M.D. | Chief Medical Officer |
Mr. Joseph R. Young M.B.A. | Senior VP of Finance & Chief Accounting Officer |
Ms. S. Sandra Park J.D. | Senior VP of Legal, Healthcare,Commercial Law, Compliance & Operations |
Ms. Debra Charlesworth | Vice President of Corporate Communications |
Ms. Emma Haywood | Vice President of Marketing |
Mr. Jason S. Carter | Chief Legal Officer |
Mr. Sean P. Grant M.B.A. | Chief Financial Officer |
Mr. David L. Johnson M.B.A. | Chief Opearating Officer |
Dr. Allen Ebens B.Sc., Ph.D. | Executive Vice President of Research |
Vera Therapeutics Inc share price today is $28.3 as on at the close of the market. Vera Therapeutics Inc share today touched a day high of $29.04 and a low of $27.69.
Vera Therapeutics Inc share touched a 52 week high of $51.27 on and a 52 week low of $18.53 on . Vera Therapeutics Inc stock price today i.e. is closed at $28.3,which is 44.80% down from its 52 week high and 52.73% up from its 52 week low.
Vera Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Vera Therapeutics Inc (VERA) shares with as little as ₹88.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.40 in Vera Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Vera Therapeutics Inc share’s latest price of $28.3 as on November 15, 2025 at 2:29 am IST, you will get 0.3534 shares of Vera Therapeutics Inc. Learn more about
fractional shares .